KYTHERA Biopharmaceuticals Inc (NASDAQ:KYTH)
| 25.54 Data as of Jun 18 |  -0.64 / -2.44%Today’s Change | 14.07 Today|||52-Week Range 31.93 | -15.82% Year-to-Date |
Latest KYTH News | Press Releases
No recent news for KYTHERA Biopharmaceuticals Inc.
Today’s Trading
| Previous close | 26.18 |
| Today’s open | 26.12 |
| Day’s range | -- - -- |
| Volume | 64,901 |
| Average volume (3 months) | 71,551 |
| Market cap | $469.6M |
| Dividend yield | -- |
Data as of 06/18/2013
Growth & Valuation
| Earnings growth (last year) | -307.97% |
| Earnings growth (this year) | -12.88% |
| Earnings growth (next 5 years) | +10.00% |
| Revenue growth (last year) | +51.61% |
| P/E ratio | NM |
| Price/Sales | 21.67 |
| Price/Book | 6.79 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CCMPCabot Microelectroni... | +1.11 | +3.25% |
| IKNXIkonics Corp | +0.73 | +4.89% |
| PPOPolypore Internation... | +0.02 | +0.05% |
Data as of 4:02pm ET, 06/18/2013
Financials
| Next reporting date | August 28, 2013 |
| EPS forecast (this quarter) | -$0.70 |
| Annual revenue (last year) | $19.7M |
| Annual profit (last year) | -$36.8M |
| Net profit margin | -186.92% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
President, Chief Executive Officer & Director Keith R. Leonard, Jr., MBA |
Senior Vice President- Operations Jeffrey D. Webster, MBA |
Corporate headquarters Calabasas, California |
Forecasts
